INTERPARFUMS INC IPAR

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations Nasdaq

Founded in 1982, we operate in the fragrance business, and manufacture, market and distribute a wide array of prestige fragrances, and fragrance related products. Our worldwide headquarters and the office of our wholly owned United States subsidiary, Interparfums, USA LLC, are located at 551 Fifth Avenue, New York, New York 10176, and our telephone number is 212.983.2640. We also have wholly owned subsidiaries as follows:

Manufacture, market and distribute a wide array of prestige fragrances, and fragrance related products

Our consolidated majority owned subsidiary, Interparfums SA, maintains executive offices at 10 rue de Solférino, 75007 Paris, France. Our telephone number in Paris is 331.5377.0000. Interparfums SA also has wholly owned subsidiaries as follows:

Last close 116.69 2026-09-04
Market cap $3.74B 2026-06-30 share count
52-week range 77.21 - 129.29

Valuation FY2025 figures against the last close

P/S2.5x
P/E22.3x
P/FCF19.6x
EV/EBITDA12.8x
Dividend yield2.7%
Diluted EPS5.24

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.49B$1.45B$1.32B$1.09B$879.5M$539.0M$713.5M$95.1M$591.3M$521.1M
Cost of revenue $541.3M$525.0M$478.6M$392.2M$322.6M$208.3M$267.6M$248.0M$215.0M$194.6M
Gross profit $947.2M$927.3M$839.1M$694.4M$556.9M$330.7M$445.9M$427.6M$376.3M$326.5M
SG&A $676.9M$648.5M$587.7M$492.4M$406.5M$260.6M$341.2M$332.8M$295.5M$258.8M
Operating income $270.3M$274.8M$251.4M$194.3M$148.1M$70.1M$104.7M$94.7M$78.6M$66.7M
Interest expense $7.2M$7.8M$11.3M$3.6M$2.8M$2.0M$2.1M$2.6M$2.0M$2.3M
Pre-tax income $271.3M$268.4M$249.6M$194.2M$151.0M$69.3M$105.1M$95.9M$78.1M$67.1M
Income tax $63.2M$65.0M$61.8M$43.2M$41.0M$19.4M$29.1M$26.1M$22.8M$23.8M
Net income $208.0M$203.0M$188.0M$151.0M$110.0M$38.2M$60.2M$53.8M$41.6M$33.3M
EPS, basic 5.255.134.773.802.761.211.921.721.331.07
EPS, diluted 5.245.124.753.782.751.211.901.711.331.07
Shares, diluted (wtd. avg.) $32.1M$32.1M$32.1M$32.0M$31.8M$31.7M$31.7M$31.52B$31.3M$31.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $159.61B$169.7M$133.4M$193.1M$208.3M$161.8M
Short-term investments $137.1M$109.3M$94.3M$150.8M$160.0M$126.6M$119.7M$67.9M$69.9M$94.2M
Receivables $320.6M$274.7M$247.2M$197.6M$159.3M$124.1M$133.0M$133.3M$120.7M$104.8M
Inventory $351.4M$371.9M$371.9M$290.0M$198.9M$158.8M$167.8M$161.8M$137.1M$97.0M
Total current assets $1.03B$926.4M$839.0M$787.7M$709.7M$600.7M$573.3M$571.6M$549.3M$472.1M
Property, plant and equipment $184.9M$153.8M$169.2M$166.7M$149.4M$19.6M$11.1M$9.8M$10.3M$10.1M
Other intangibles $325.2M$282.5M$296.4M$290.9M$214.0M$214.1M$202.0M$204.3M$200.5M$183.9M
Total assets $1.59B$1.41B$1.37B$1.31B$1.15B$890.1M$828.8M$797.8M$777.8M$682.4M
Accounts payable $77.2M$91.0M$97.4M$88.4M$82.0M$35.6M$54.1M$58.3M$52.6M$49.5M
Short-term debt $54.8M$41.6M$29.6M$28.5M$15.9M$14.6M$12.3M$23.2M$24.4M$21.5M
Total current liabilities $344.0M$332.4M$324.7M$344.6M$244.9M$156.2M$184.5M$189.2M$167.1M$142.2M
Long-term debt $121.3M$115.7M$127.9M$151.5M$132.9M$10.1M$10.7M$22.9M$36.2M$53.1M
Retained earnings $828.9M$763.2M$693.8M$620.1M$560.7M$503.6M$474.6M$448.7M$422.6M$402.7M
Total equity $880.7M$744.9M$892.2M$788.1M$738.3M$702.5M$609.0M$585.7M$570.6M$483.7M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $214.9M$187.6M$105.8M$73.0M$119.6M$65.0M$76.5M$63.0M$35.9M$54.6M
Depreciation and amortisation $25.3M$28.4M$17.3M$22.5M$12.7M$9.1M$3.7M$4.1M$3.8M$3.7M
Stock-based compensation $1.6M$2.4M$2.5M$3.1M$2.9M$3.0M$3.4M$2.2M$2.1M$1.2M
Capital expenditure $24.4M$4.7M$6.5M$33.8M$141.3M$11.0M$5.4M$4.0M$3.0M$4.8M
Investing cash flow -$61.1M-$44.8M$7.3M-$90.6M-$187.9M-$22.3M-$64.6M-$13.6M$36.9M-$20.4M
Financing cash flow -$131.3M-$100.8M-$133.2M-$45.6M$78.2M-$18.6M-$68.2M-$55.9M-$47.6M-$44.6M
Dividends paid $102.7M$96.0M$80.0M$63.7M$31.7M$20.8M$34.6M$26.3M$21.2M$18.0M
Buybacks $77.0K

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001753926-26-001295.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $70.77B 33.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $37.63B 207.7x 5.0%
KVUE Kenvue Inc. $36.00B 24.7x -2.1%
ELF e.l.f. Beauty, Inc. $6.47B 249.2x 24.6%
COTY COTY INC. $2.58B -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.33B 54.5x -1.3%
WALD Waldencast plc $156.3M -0.7%
SLSN SOLESENCE, INC. $60.0M 42.5x 18.6%